Skip to main content
Clinical Trials/NCT03195309
NCT03195309
Unknown
Phase 1

A Comparison of Different Concentration Ropivacaine Combination With Fentanyl for Patient-controlled Epidural Analgesia After Cesarean Delivery

Kaohsiung Medical University Chung-Ho Memorial Hospital1 site in 1 country120 target enrollmentJanuary 20, 2017

Overview

Phase
Phase 1
Intervention
Ropivacaine
Conditions
Epidural Anesthesia
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Enrollment
120
Locations
1
Primary Endpoint
Change From Baseline in Pain Scores on the numeric rating scale
Last Updated
8 years ago

Overview

Brief Summary

To compare the postoperative analgesic effect and the intensity of motor block in different concentration ropivacaine plus fentanyl when used epidurally with a patient-controlled analgesia device after Cesarean delivery.

Detailed Description

1. Written informed consent must be obtained before any study specific procedures are undertaken. 2. All patients were received epidural anesthesia with 2% Lidocaine and patient-controlled epidural analgesia (PCEA) for post- operative pain control. PCEA randomly allocated into three groups. Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl, Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl, and Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl. Dermographic data, dosage of PCEA during first 48 hours post-operation,NRS scores, patient satisfaction and the intensity of motor block will be recorded and analyzed.

Registry
clinicaltrials.gov
Start Date
January 20, 2017
End Date
June 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female undergoing elective Cesarean delivery and receive patient-controlled epidural analgesia

Exclusion Criteria

  • With the comorbidity of chronic heart, lung, liver and renal disease, chronic alcoholism, allergy to ropivacaine, poor epidural function and combine other anesthesia method

Arms & Interventions

Group A

Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl

Intervention: Ropivacaine

Group A

Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl

Intervention: Fentanyl

Group B

Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl

Intervention: Ropivacaine

Group B

Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl

Intervention: Fentanyl

Group C

Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl

Intervention: Ropivacaine

Group C

Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl

Intervention: Fentanyl

Outcomes

Primary Outcomes

Change From Baseline in Pain Scores on the numeric rating scale

Time Frame: The investigators measured numeric score changing at 5 different timing. The first is when arrival post-operative care unit, the second is when arrival post-operative care unit for 2 hours. And then 6,24,48 hours after operation.

The investigators use numeric rating scale(0\~10) for pain severity measurement, 0 for no pain, 10 is the most severe pain

Secondary Outcomes

  • Change From Baseline in Patient satisfaction scale(The investigators measured numeric score changing at 5 different timing. The first is when arrival post-operative care unit, the second is when arrival post-operative care unit for 2 hours. And then 6,24,48 hours after operation.)

Study Sites (1)

Loading locations...

Similar Trials